Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

Accueil
Investir
ETFs
Etats-Unis
AMEX
Virtus Biotech Clinical Trials ETF (BBC)
Virtus Biotech Clinical Trials ETF (BBC) Options

Virtus Biotech Clinical Trials ETF (BBC)

40,66

-2,30

(-5,35%)

Fermé 07 Juin 10:00PM

40,66

0,00

(0,00%)

Après les heures de négociation: 10:07PM

Virtus Biotech Clinical Trials ETF ([symbol]) Options

BBC Flux des options

Achats

Strike	Achat	Vente	Dernier Prix	Point Médian	Var	Var %	Volume	INT OUVERT	Dernière Trans
37,00	3,00	5,00	0,00	4,00	0,00	0,00 %	0	0	-
38,00	2,20	4,20	0,00	3,20	0,00	0,00 %	0	0	-
39,00	1,40	3,30	0,00	2,35	0,00	0,00 %	0	0	-
40,00	1,15	2,65	0,00	1,90	0,00	0,00 %	0	0	-
41,00	0,25	2,10	3,05	1,175	0,00	0,00 %	0	4	-
42,00	0,10	1,70	0,00	0,90	0,00	0,00 %	0	0	-
43,00	0,10	1,35	2,10	0,725	0,00	0,00 %	0	7	-
44,00	0,00	1,25	0,00	0,00	0,00	0,00 %	0	0	-
45,00	0,10	1,15	0,00	0,625	0,00	0,00 %	0	0	-
46,00	0,00	1,05	0,00	0,00	0,00	0,00 %	0	0	-
47,00	0,00	1,00	0,00	0,00	0,00	0,00 %	0	0	-
48,00	0,00	1,00	0,00	0,00	0,00	0,00 %	0	0	-
49,00	0,00	1,05	0,00	0,00	0,00	0,00 %	0	0	-
50,00	0,00	1,00	1,70	1,70	0,00	0,00 %	0	2	-

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Ventes

Strike	Achat	Vente	Dernier Prix	Point Médian	Var	Var %	Volume	INT OUVERT	Dernière Trans
37,00	0,00	1,25	0,00	0,00	0,00	0,00 %	0	0	-
38,00	0,00	1,35	0,00	0,00	0,00	0,00 %	0	0	-
39,00	0,00	1,60	0,00	0,00	0,00	0,00 %	0	0	-
40,00	0,05	1,95	0,00	1,00	0,00	0,00 %	0	0	-
41,00	0,50	2,50	0,00	1,50	0,00	0,00 %	0	0	-
42,00	1,15	3,10	0,70	2,125	0,00	0,00 %	0	4	-
43,00	1,80	3,90	0,00	2,85	0,00	0,00 %	0	0	-
44,00	2,75	4,60	0,00	3,675	0,00	0,00 %	0	0	-
45,00	3,50	5,40	4,01	4,45	0,00	0,00 %	0	4	-
46,00	4,50	6,50	0,00	5,50	0,00	0,00 %	0	0	-
47,00	5,40	7,20	0,00	6,30	0,00	0,00 %	0	0	-
48,00	6,30	8,40	0,00	7,35	0,00	0,00 %	0	0	-
49,00	7,30	9,40	0,00	8,35	0,00	0,00 %	0	0	-
50,00	8,40	10,40	0,00	9,40	0,00	0,00 %	0	0	-

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
SCAGScage Future	US$ 0,8489 (196,61%)	92,75M
SPHLSpringview Holdings Ltd	US$ 5,38 (125,20%)	40,61M
NOTVInotiv Inc	US$ 0,1638 (89,15%)	1,07B
RMSGReal Messenger Corporation	US$ 1,809 (64,45%)	199,97M
STISolidion Technology Inc	US$ 35,50 (56,32%)	38,55M
NUWENewellis Inc	US$ 0,1625 (-62,30%)	50M
NYXHNyxoah SA	US$ 1,41 (-51,04%)	2,47M
CYPHCypherpunk Technologies Inc	US$ 0,5176 (-47,26%)	30,53M
TDICDreamland Ltd	US$ 0,2277 (-37,68%)	12,09M
FOFOHang Feng Technology Innovation Co Ltd	US$ 3,91 (-36,73%)	381,9k
NOTVInotiv Inc	US$ 0,1638 (89,15%)	1,07B
SNBRSleep Number Corporation	US$ 0,477 (36,25%)	305,13M
SMTKSmartKem Inc	US$ 0,419101 (30,97%)	232,19M
NVDANVIDIA Corporation	US$ 205,10 (-6,20%)	220,65M
RMSGReal Messenger Corporation	US$ 1,809 (64,45%)	199,97M

stoxjock

stoxjock il y a 3 minutes

Ron,
Are the RE going into the WFC Trusts or US Bank's ones or both?
TIA & GLTU!

jondoeuk

jondoeuk il y a 5 minutes

OT: 'A PRINTed GLA medicine that addresses the multi-organ impact of Fabry and deliver multi-year durability without the challenges of frequent dosing or viral vector-based delivery would be transformative for patients.' https://www.globenewswire.com/news-release/2026/05/12/3292599/0/en/addition-the

stoxjock

stoxjock il y a 5 minutes

Husshh. Shhh.. Let Not the Word out Yet! Let us first get our WaMu 'Buckets' so that we Load up More of FnF...Lol!

1manband

1manband il y a 6 minutes

If anyone is interested in a Whistleblower award for stock fraud, the SEC's program is a very high bar. Besides only paying once a monetary penalty is received by the Commission, the program also requires a long application process and any payments may come years after the tip is first given.

ScottishTexan

ScottishTexan il y a 7 minutes

Search $vgls on X

getmoreshares

getmoreshares il y a 8 minutes

lots of clown BS-- over 3/4 of the weekend posts-- Glad most of us do not waste our time reading them

skitahoe

skitahoe il y a 11 minutes

The type of trial you're suggesting will never happen again, at least not with the DCVax's IMHO. The FDA and others are recognizing the benefits of treating all in a trial and letting the results go against the existing data for the disease in question. I believe that few trials in the future agai

Ridetherocket

Ridetherocket il y a 15 minutes

Hold on , I'm obviously not as smart as you guys when it comes to this, BUT if it does an IPO all I will get is 1 share for every 23 I have now? So say I have 23,000 now, that becomes only 1000 after Ipo. Unless you have a million shares why in the world have I been holding on fnma for last six mt

Sammy boy

Sammy boy il y a 18 minutes

Then we have Bill Pulte, I wish I could invest in these companies when the stock was trading near $13. Stock dips below $7 and the sleaze bag says nothing, tells you a lot about his character, nice guy!

gfp927z

gfp927z il y a 19 minutes

Elton John -

https://youtu.be/8K5ecDiuQEE?list=RD8K5ecDiuQEE

---

delerious1

delerious1 il y a 21 minutes

"...it's an acronym." No it isn't.....er, an acronym....

DewDiligence

DewDiligence il y a 28 minutes

Lilly also reported cases of dysesthesia, an abnormal sensation such as tingling or burning… IMO, this could turn out to be a pretty big impediment to commercial uptake (assuming regulatory approval). The dysesthesia issue was discussed on this board when LLY announced the topline results two weeks

meirluc

meirluc il y a 29 minutes

Doc, if Flaskworks is not happening, why on earth is NWBO working to update the electrical infrastructure of the Grade C suite and complete the buildout of that suite?

As for whether Flaskworks is done or on the way is a question to be asked after that C suite work has been completed

GoodGuyBill

GoodGuyBill il y a 32 minutes

Gary, normally I’d agree with you — in most cases, guys like Griffin write a inconsequential check, shrug it off, and the story ends. But the scale and duration of the misconduct here is so large, so well-documented, and so interconnected across multiple companies since 2017, that this isn’t just an

TightCoil

TightCoil il y a 32 minutes

i'm on your side, with ya all the way,
i been tellin' 'em that for years, but no
one ever listens...and the PPS keeps goin' up.
keep trying, keep fightin' - we need you to be our leader

Longstrongsilver

Longstrongsilver il y a 34 minutes

Yeah! Those shares are as restricted as Josh is. Locked up tight!

Scope08

Scope08 il y a 39 minutes

Thanks for doing the legwork on this Carl. For future reference. I’m in agreement on the no buy out stance.

Porch Honkey

Porch Honkey il y a 40 minutes

They barely Hanging on, cash is running out, good luck getting out.

berta

berta il y a 42 minutes

Longs Trust in the ongoing process I believe.
JMHO..

JD400

JD400 il y a 44 minutes

LIVE | Trump Administration Releases New Declassified UFO Files, Shocking Alien Evidence Testimony

Streamed live 10 hours ago #ufobombshell #usnewslive #ufotestimony

Trump Administration Releases New Declassified UFO Files LIVE: Shocking Alien Evidence Testimony

EddytheEagle

EddytheEagle il y a 44 minutes

You are foolish to argue the effectiveness of dcvax combined with other therapeutics until it is proven in a well designed, randomized, double blind, placebo controlled clinical trial. All you have is a hypothesis. And you will never get MAA approval when all you have is a hypothesis.

Major Profits

Major Profits il y a 45 minutes

"I got as far as : " Afaic" ??????"
Well, as far as I'm concerned, and from what I've gathered, it could be written "AFAIC" or "afaic" but since it was the first letter of a sentence I figured it would be "Afaic". Er, it's an acronym. But you knew that, huh? I hope. 😂

D

sometimes_right

sometimes_right il y a 47 minutes

MAYBE Trump will instead utilize Legacy WMI assets, perhaps with Lehman's NOLs, to initially start up the suggested Great American Mortgage Corporation and merge with Fannie and Freddie at some later date when conditions are more favorable?

My gosh, they need some stimulation for our

ptk123

ptk123 il y a 54 minutes

Virtus Biotech Clinical ...

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

ADVFN

Vous avez déjà un compte? Connexion

Vous n'avez pas de compte ? Inscription

En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.